← Eichor
Study identifier: NCT07083050 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Non-Inferiority of Fibroguide Collagen Membrane Compared to Autologous Connective Tissue Graft for Coverage of Multiple Adjacent Recession. Multicenter Trial.

Condition: Gingival Recession, Plastic Surgery  ·  Sponsor: Maurizio Tonetti

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study deals with coverage of multiple denuded roots. The current standard treatment requires surgical correction and uses soft tissue taken from the roof of the mouth to enhance results. The hypothesis of this trial is that a synthetic collagen matrix (called Fibrogide) can be used to replace soft tissue taken from the subject. If the collagen matrix will prove to be equally as effective as the patient own tissue, it will be possible to avoid a more extensive surgery and decrease pain and discomfort.

This description comes directly from the study's public registry record.

Talk to the study team

Maurizio Tonetti, DMD, PhD  ·  393473289709  ·  maurizio.tonetti@ergoperio.eu

Luigi Barbato, DMD, PhD  ·  39-3299457556  ·  luigi.barbato@unifi.it

Always discuss trial participation with your own doctor first.

Locations (2)

Ospedale CareggiFlorence, ItalyRecruiting
International University of CatalunyaBarcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07083050